Hypoxia-induced and stress-specific changes in chromatin structure and function.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMC 1924842)

Published in Mutat Res on January 21, 2007

Authors

Amber Buescher Johnson1, Michelle Craig Barton

Author Affiliations

1: Department of Biochemistry and Molecular Biology, Program in Genes and Development, Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Articles citing this

Protein damage by reactive electrophiles: targets and consequences. Chem Res Toxicol (2007) 2.31

Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth. Mol Cell Biol (2010) 2.17

Hypoxia induces a novel signature of chromatin modifications and global repression of transcription. Mutat Res (2008) 1.61

Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy. Mol Cell Endocrinol (2011) 1.22

RNA-binding proteins implicated in the hypoxic response. J Cell Mol Med (2009) 1.15

The control of histone methylation and gene expression by oxidative stress, hypoxia, and metals. Free Radic Biol Med (2012) 1.08

Post-Transcriptional Control of the Hypoxic Response by RNA-Binding Proteins and MicroRNAs. Front Mol Neurosci (2011) 1.06

Priming adult stem cells by hypoxic pretreatments for applications in regenerative medicine. J Biomed Sci (2013) 1.00

Febrile-range temperature modifies cytokine gene expression in LPS-stimulated macrophages by differentially modifying NF-{kappa}B recruitment to cytokine gene promoters. Am J Physiol Cell Physiol (2009) 1.00

Neuroglobin-deficiency exacerbates Hif1A and c-FOS response, but does not affect neuronal survival during severe hypoxia in vivo. PLoS One (2011) 0.97

Polymorphisms in two DNA repair genes (XPD and XRCC1)--association with age related cataracts. Mol Vis (2011) 0.96

Epigenetic mechanisms in cerebral ischemia. J Cereb Blood Flow Metab (2013) 0.93

Epigenetics: new questions on the response to hypoxia. Int J Mol Sci (2011) 0.93

Tumor hypoxia as a driving force in genetic instability. Genome Integr (2013) 0.92

Endoplasmic reticulum stress, genome damage, and cancer. Front Oncol (2015) 0.90

Corepressors (NCoR and SMRT) as well as coactivators are recruited to positively regulated 1α,25-dihydroxyvitamin D3-responsive genes. J Steroid Biochem Mol Biol (2012) 0.88

Epigenetic alterations in acute kidney injury. Semin Nephrol (2013) 0.88

The nuclear localization of SWI/SNF proteins is subjected to oxygen regulation. Cell Biosci (2012) 0.87

Hypoxia elicits broad and systematic changes in protein subcellular localization. Am J Physiol Cell Physiol (2011) 0.85

On the epigenetics of vascular regulation and disease. Clin Epigenetics (2012) 0.85

Formation of stress-specific p53 binding patterns is influenced by chromatin but not by modulation of p53 binding affinity to response elements. Nucleic Acids Res (2010) 0.84

Genetic variability in DNA repair proteins in age-related macular degeneration. Int J Mol Sci (2012) 0.83

Variable promoter methylation contributes to differential expression of key genes in human placenta-derived venous and arterial endothelial cells. BMC Genomics (2013) 0.82

Quantitative profiling of chromatome dynamics reveals a novel role for HP1BP3 in hypoxia-induced oncogenesis. Mol Cell Proteomics (2014) 0.82

The role of epigenetics in age-related macular degeneration. Eye (Lond) (2014) 0.81

Effect of dietary lead on intestinal nutrient transporters mRNA expression in broiler chickens. Biomed Res Int (2015) 0.81

H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK. Oncogene (2015) 0.80

Environmental preconditioning rejuvenates adult stem cells' proliferation and chondrogenic potential. Biomaterials (2016) 0.78

Hypoxia-Inducible Histone Lysine Demethylases: Impact on the Aging Process and Age-Related Diseases. Aging Dis (2016) 0.77

Molecular mechanisms of hypoxia in cancer. Clin Transl Imaging (2017) 0.75

Articles cited by this

(truncated to the top 100)

Translating the histone code. Science (2001) 56.77

Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature (1997) 44.55

Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer (2002) 20.51

The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol (2005) 12.70

Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell (1999) 11.90

Cooperation between complexes that regulate chromatin structure and transcription. Cell (2002) 10.38

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (1996) 10.14

Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev (2001) 9.54

Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol (1999) 9.32

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst (2001) 8.57

Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science (2002) 8.27

Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature (1997) 7.66

Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell (1997) 7.64

FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev (2002) 7.08

FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev (2001) 6.35

Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell (1997) 6.27

Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol (2004) 6.00

Histone lysine methylation: a signature for chromatin function. Trends Genet (2003) 5.55

HIF-1 and human disease: one highly involved factor. Genes Dev (2000) 5.41

Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science (2001) 5.25

Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev (2005) 4.61

An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci U S A (1996) 4.57

Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem (2000) 4.36

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem (2001) 4.21

Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol Cell (2006) 4.20

Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep (2002) 4.13

Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell (2003) 4.13

Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci. Science (2003) 3.97

Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem (2002) 3.91

Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med (2001) 3.87

Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med (2000) 3.72

Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J (1998) 3.63

CBP and p300: HATs for different occasions. Biochem Pharmacol (2004) 3.38

Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. EMBO J (2000) 3.35

Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol (1994) 3.30

Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell (2002) 3.28

Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc Natl Acad Sci U S A (2002) 3.28

Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med (2001) 3.07

Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol Cell (2003) 3.06

Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med (2004) 3.04

The histone code at DNA breaks: a guide to repair? Nat Rev Mol Cell Biol (2005) 2.97

The hypoxic response: huffing and HIFing. Cell (1997) 2.94

Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem (2002) 2.82

Functional significance of histone deacetylase diversity. Curr Opin Genet Dev (2001) 2.79

The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol (2004) 2.74

Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist (2004) 2.72

Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem (2000) 2.70

BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J Exp Med (2003) 2.62

Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol Cell Biol (2000) 2.61

STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J (2005) 2.60

Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev (1999) 2.51

Activation of the HIF pathway in cancer. Curr Opin Genet Dev (2001) 2.38

Negative and positive regulation of HIF-1: a complex network. Biochim Biophys Acta (2005) 2.27

Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol (2004) 2.23

Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Nat Struct Biol (2003) 2.23

Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol (2001) 2.19

Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol (2003) 2.12

The genome-wide localization of Rsc9, a component of the RSC chromatin-remodeling complex, changes in response to stress. Mol Cell (2002) 2.10

ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J Biol Chem (2003) 2.09

Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes Dev (2000) 2.07

Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications. Genes Dev (2005) 2.01

Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases. Biochem Biophys Res Commun (2005) 1.99

Molecular mechanism of hypoxia-inducible factor 1alpha -p300 interaction. A leucine-rich interface regulated by a single cysteine. J Biol Chem (2000) 1.93

MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Lett (2003) 1.92

Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol Cell Biol (2006) 1.89

Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol Cell Biol (1998) 1.80

The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem Cell Biol (2005) 1.79

Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol (2001) 1.76

Complicated tails: histone modifications and the DNA damage response. Cell (2005) 1.74

The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc Natl Acad Sci U S A (2005) 1.73

Targeting histone deacetylase in cancer therapy. Med Res Rev (2006) 1.69

Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. EMBO J (2005) 1.68

MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J Biol Chem (2003) 1.66

The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation. Proc Natl Acad Sci U S A (2002) 1.64

Mitogen-stimulated phosphorylation of histone H3 is targeted to a small hyperacetylation-sensitive fraction. Proc Natl Acad Sci U S A (1994) 1.63

Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia (2005) 1.62

Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing. J Appl Physiol (1985) (2005) 1.54

p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest. Mol Cell Biol (2001) 1.53

Structure of factor-inhibiting hypoxia-inducible factor 1: An asparaginyl hydroxylase involved in the hypoxic response pathway. Proc Natl Acad Sci U S A (2002) 1.53

Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res (2005) 1.52

The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Cancer Res (2004) 1.47

Endoplasmic reticulum stress induction of the Grp78/BiP promoter: activating mechanisms mediated by YY1 and its interactive chromatin modifiers. Mol Cell Biol (2005) 1.46

Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol (2002) 1.36

Transcriptional activation domains of human heat shock factor 1 recruit human SWI/SNF. Mol Cell Biol (2001) 1.29

Chromatin condensation is not associated with apoptosis. J Biol Chem (1998) 1.27

Inducible covalent posttranslational modification of histone H3. Sci STKE (2005) 1.26

Functional analysis of p53 binding under differential stresses. Mol Cell Biol (2006) 1.25

Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha. J Biol Chem (2006) 1.24

HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem Pharmacol (2004) 1.22

Hypoxia and anemia: effects on tumor biology and treatment resistance. Transfus Clin Biol (2005) 1.21

Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours. Br J Cancer (2005) 1.21

S-nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity. FEBS Lett (2003) 1.20

Functional analysis of hypoxia-inducible factor-1 alpha-mediated transactivation. Identification of amino acid residues critical for transcriptional activation and/or interaction with CREB-binding protein. J Biol Chem (2002) 1.19

Nickel carcinogenesis: epigenetics and hypoxia signaling. Mutat Res (2005) 1.19

Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. J Biol Chem (2004) 1.19

p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1). Biochem J (2004) 1.19

Coactivator-associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17. Mol Endocrinol (2006) 1.14

Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis. Int J Cancer (2002) 1.11

Hypoxia: the tumor's gateway to progression along the angiogenic pathway. Trends Cell Biol (2001) 1.10

Role of CBP in regulating HIF-1-mediated activation of transcription. J Cell Sci (2004) 1.09

Articles by these authors

TRIM24 links a non-canonical histone signature to breast cancer. Nature (2010) 2.99

Trim24 targets endogenous p53 for degradation. Proc Natl Acad Sci U S A (2009) 2.00

p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol (2012) 1.63

Hypoxia induces a novel signature of chromatin modifications and global repression of transcription. Mutat Res (2008) 1.61

Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver. Proc Natl Acad Sci U S A (2008) 1.38

Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene. Mol Cell Biol (2005) 1.24

A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene. Mol Cell Biol (2005) 1.22

p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo. Mol Cell Biol (2008) 1.15

Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription. J Biol Chem (2005) 1.15

Regulation of p53: TRIM24 enters the RING. Cell Cycle (2009) 1.11

Hypoxia actively represses transcription by inducing negative cofactor 2 (Dr1/DrAP1) and blocking preinitiation complex assembly. J Biol Chem (2002) 1.10

p53 regulates a mitotic transcription program and determines ploidy in normal mouse liver. Hepatology (2013) 1.05

Genome-wide profiling reveals stimulus-specific functions of p53 during differentiation and DNA damage of human embryonic stem cells. Nucleic Acids Res (2013) 1.02

Chromatin-bound p53 anchors activated Smads and the mSin3A corepressor to confer transforming-growth-factor-beta-mediated transcription repression. Mol Cell Biol (2008) 0.99

Foxa1 functions as a pioneer transcription factor at transposable elements to activate Afp during differentiation of embryonic stem cells. J Biol Chem (2010) 0.99

Analysis of epigenetic alterations to chromatin during development. Genesis (2009) 0.98

Ubp8 and SAGA regulate Snf1 AMP kinase activity. Mol Cell Biol (2011) 0.91

Cascades of transcription regulation during liver regeneration. Int J Biochem Cell Biol (2010) 0.89

Neuronal transcriptional repressor REST suppresses an Atoh7-independent program for initiating retinal ganglion cell development. Dev Biol (2010) 0.88

Making sense of ubiquitin ligases that regulate p53. Cancer Biol Ther (2010) 0.85

Many forkheads in the road to regulation. Symposium on forkhead transcription factor networks in development, signalling and disease. EMBO Rep (2008) 0.83

Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice. Hepatology (2010) 0.83

Unmet expectations: miR-34 plays no role in p53-mediated tumor suppression in vivo. PLoS Genet (2012) 0.82

The APC tumor suppressor promotes transcription-independent apoptosis in vitro. Mol Cancer Res (2005) 0.81

Hierarchies of transcriptional regulation during liver regeneration. Prog Mol Biol Transl Sci (2010) 0.78

Integrative genomics: liver regeneration and hepatocellular carcinoma. J Cell Biochem (2012) 0.77

Microarray analysis of hepatic-regulated gene expression: specific applications and nonspecific problems. Hepatology (2002) 0.76

HDAC3 at the fulcrum of an epithelial-mesenchymal balance. Mol Cell (2011) 0.76

p53-Mediated regulation of hepatic lipid metabolism: forging links between metabolism, atherogenesis, and cancer. J Hepatol (2011) 0.75

Hierarchy of a regenerative cell cycle: cyclin E1 multitasks. Hepatology (2013) 0.75